INSTANYL

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

fentanyl citrate, Quantity: 0.785 mg/mL (Equivalent: fentanyl, Qty 0.5 mg/mL)

Mevcut itibaren:

Takeda Pharmaceuticals Australia Pty Ltd

INN (International Adı):

Fentanyl citrate

Farmasötik formu:

Spray, nasal

Kompozisyon:

Excipient Ingredients: monobasic sodium phosphate dihydrate; dibasic sodium phosphate dihydrate; purified water

Uygulama yolu:

Nasal

Paketteki üniteler:

2 bottles per carton, 8 bottles per carton, 6 bottles per carton, 10 bottles per carton

Reçete türü:

(S8) Controlled Drug

Terapötik endikasyonlar:

Instanyl is indicated for the management of breakthrough pain in adults already receiving maintenance opioid therapy for chronic cancer pain.

Ürün özeti:

Visual Identification: Nasal spray; Container Type: Bottle, with integral pump - manual actuated; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2013-06-17